HOME >> BIOLOGY >> NEWS
New study may show how to forestall a fatal, virus-caused immune-system meltdown

GALVESTON, Texas When a virus infects a person, it triggers a series of biochemical reactions in immune-system cells that literally may have life or death consequences.

Usually, the result is an effective immune response, leading to the elimination of the virus and the infected persons recovery. But in the case of some of the worlds deadliest pathogens including the Ebola, Marburg and Lassa fever viruses, as well as the influenza virus strain responsible for the 1918 flu pandemic the immune system itself actually becomes the most dangerous element of the disease. All too often, a sudden immune overreaction sends the infected person into a shock-like state from which he or she may never recover.

Now, researchers at the University of Texas Medical Branch at Galveston (UTMB) believe theyve found a way to spot the biochemical profile of an inappropriate immune response to viral infection an important step toward developing new therapies that may head off or stop an otherwise fatal immune system meltdown.

In a paper published in the February 14 issue of the Journal of Virology, highlighted in the journals Spotlight section and available now online, the scientists describe using a newly developed protein-scanning chip and a uniquely capable computer database to examine the activation and deactivation of more than a thousand proteins in cells from guinea pigs infected with two different strains of Pichinde virus. Guinea pigs infected with one of the Pichinde strains experience no ill effects, while those infected with the other strain develop symptoms similar to those seen in humans infected by the much more dangerous Lassa virus, which can cause an acute hemorrhagic fever and kills about 5,000 people a year in West Africa. (During some Lassa fever epidemics, as many as 50 percent of those diagnosed with the disease have died from it.)

With these two forms of the virus and this new technology, we were able to compare pathog
'"/>

Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston
14-Feb-2007


Page: 1 2 3

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. Multicenter study nets new lung tumor-suppressor gene
9. MIT study: Maturity brings richer memories
10. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
11. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer

Post Your Comments:
(Date:6/19/2013)... A decade-long JDRF-funded study led by the Institute ... is providing a deeper understanding of the link ... 1 diabetes (T1D), highlighting the importance of pre-diabetes ... study, "Seroconversion to Multiple Islet Autoantibodies and Risk ... today in The Journal of the American ...
(Date:6/19/2013)... Cornell University study offers further proof that the divergence ... million years ago was profoundly influenced by mutations to ... and off. , The study, published June 9 in ... hypothesis that regulation of genes must play an important ... humans and chimps in the proteins produced by genes. ...
(Date:6/18/2013)... Calgary,s Faculty of Medicine have discovered a mechanism that ... Platelets, a component of blood typically associated with clotting, ... upon detection, seal it off from the rest of ... Nature Immunology this week, provide the science community ... community has known that platelets do participate in immunity, ...
Breaking Biology News(10 mins):New data on islet autoantibodies in young children defines early type 1 diabetes development 2New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3Immunity mechanism discovered 2
(Date:6/19/2013)... June 19, 2013 ... presents Innovative Drug Delivery Systems: ... Licensing Opportunities for Generic Pharmaceutical ... There are more than ... drugs approved all over the ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to ... of sulfur in ultra-low sulfur diesel (ULSD) using the ... analyzer . The analysis detailed in Rigaku Application Note ... This International Standard specifies an energy dispersive X-ray fluorescence ... in automotive gasoline. , Regulations around the world have ...
(Date:6/19/2013)... Adding to their already extensive supply of ... Dropette® and Heathrow Scientific disposable plastic transfer ... biology, chemistry and any type of liquid handling analysis ... years, Simport has been supplying the science community with ... Simport Dropette®. Simport’s Dropette® is a one-piece plastic ...
(Date:6/18/2013)... KONG, June 18, 2013 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2013 ended March 31, 2013. Fourth ... the fourth quarter of fiscal 2013 increased by 33.3% ...
Breaking Biology Technology:Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13
Cached News: